Loss of TIGAR or NRF2 antioxidant proteins delays the initiation of tumors but elevates ROS levels in pancreatic cancer cells, facilitating a phenotypic shift that enhances invasion and metastatic potential. The gene discussed is NFE2L2; the disease is familial pancreatic carcinoma.